All Columns articles – Page 6
- 
      
         Opinion OpinionThe classic sandwichFerrocene turned our understanding of structure and bonding on its head 
- 
      
         Opinion OpinionThe UK has rejoined Horizon Europe, but the delays have been costlyThe deal to rejoin the EU’s science programme makes sense for the country and it’s well overdue 
- 
      
         Opinion OpinionResistant to changeCurbing industrial practices that drive antimicrobial resistance needs tighter regulation and enforcement 
- 
      
         Opinion OpinionSurviving in the war of all against allCancers and bacteria develop resistance to drugs in remarkably similar ways 
- 
      
          
- 
      
         Opinion OpinionNavigating the literature torrentIt’s humanly impossible to filter and read everything worthwhile – let’s embrace assistance 
- 
      
         Business BusinessAntibodies face Alzheimer’s realityCompanies are convincing regulators, but will doctors use them, and will providers pay for them? 
- 
      
         Opinion OpinionThe heavy appeal of liquid metalsThe shiny and dense fluids offer both ancient mystery and future promise 
- 
      
         Opinion OpinionThe end of chemical warfareWith a final push we might see these terrible weapons disappear from the world in our lifetime 
- 
      
         Opinion OpinionWhiteboards and napkinsHow chemical intuition and guesses become the precise numbers of chemistry 
- 
      
          
- 
      
         Opinion OpinionBringing drug manufacturing back homePharmaceutical supply chains are international, complex and opaque. Is there a better way? 
- 
      
         Opinion OpinionReturning to the moonIt’s been a while, but space agencies are starting to plan their trips back to our satellite, with the goal of building semi-permanent bases 
- 
      
         Opinion OpinionRegulators must follow their heads, not their heartsThe 2019 US approval of antibiotic Recarbrio seems not to have met the normally expected standards 
- 
      
         Opinion OpinionLessons from LieberThe prosecution of Charles Lieber has had a chilling effect on US researchers, leaving them uncertain about collaboration with overseas programmes 
- 
      
         Opinion OpinionBattery materials going up in smokeWe cannot afford to simply throw away, rather than recycle, these valuable resources 
- 
      
         Opinion OpinionWill a court overturn abortion drug’s approval?Tangle between regulation and politics makes uncomfortable viewing from industry 
- 
      
          
- 
      
         Opinion OpinionNursing success – what next for UK science?Policy prescriptions for research need cross-party support 
- 
      
         Opinion OpinionMeeting the tigers of the labPractical teaching strikes a balance between removing hazards and learning to respect them